2023-06-27 09:23:14 ET
- Biopharmaceutical company Atossa Therapeutics ( NASDAQ: ATOS ) said on Tuesday that its board has approved an up to $10M share repurchase program.
- The share repurchase program will be implemented through Dec. 31. The size of the repurchase authorization is less than 10% of total cash, as reported on Mar. 31.
- The company expects to repurchase shares from time to time in open market transactions, privately negotiated block transactions, or other means.
- ATOS shares were trading +2.25% pre-market.
- Source: Press Release
For further details see:
Atossa Therapeutics launches up to $10M share repurchase program